CGQYX
Price
$10.98
Change
-$0.28 (-2.49%)
Updated
Sep 6 closing price
GAFFX
Price
$71.60
Change
-$1.54 (-2.11%)
Updated
Sep 6 closing price
Ad is loading...

CGQYX vs GAFFX

Header iconCGQYX vs GAFFX Comparison
Open Charts CGQYX vs GAFFXBanner chart's image
Columbia Disciplined Growth Inst3
Price$10.98
Change-$0.28 (-2.49%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer F3
Price$71.60
Change-$1.54 (-2.11%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CGQYX vs GAFFX Comparison Chart
Loading...
VS
CGQYX vs. GAFFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGQYX is a Buy and GAFFX is a Buy.

FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 270B vs. CGQYX (277M). GAFFX pays higher dividends than CGQYX: GAFFX (0.75) vs CGQYX (0.00). CGQYX was incepted earlier than GAFFX: CGQYX (9 years) vs GAFFX (8 years). CGQYX is a more actively managed with annual turnover of: 71.00 vs. GAFFX (31.00). CGQYX (1000000) and GAFFX (1000000) have matching initial minimum investment requirements. GAFFX (18.82) and CGQYX (18.40) have marching annual gain over last year. GAFFX return over 5 years is better than : 47.91 vs. CGQYX (19.82).
CGQYXGAFFXCGQYX / GAFFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years8 years-
Gain YTD15.96315.819101%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets277M270B0%
Annual Yield % from dividends0.000.75-
Returns for 1 year18.4018.8298%
Returns for 3 years-14.95-6.59227%
Returns for 5 years19.8247.9141%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DM4.380.11
+2.58%
Desktop Metal
ADEA11.90N/A
N/A
Adeia
CRVL311.13-0.03
-0.01%
CorVel Corp
CTSH76.78-0.54
-0.70%
Cognizant Technology Solutions Corp
AEON0.82-0.01
-1.46%
AEON Biopharma